SANOFI-AVENTIS (EPA:SAN) Press Release: Dupixent® (dupilumab) late-breaking data at AAD show significant improvements in signs and symptoms of moderate-to-severe atopic hand and foot dermatitis
Transparency directive : regulatory news
18/03/2023 15:00
SANOFI-AVENTIS's latest news
08/06/2023 23:19
01/06/2023 07:30
21/05/2023 20:17
17/05/2023 22:01
12/05/2023 10:50
04/05/2023 08:00
27/04/2023 14:40
19/04/2023 21:05
11/04/2023 08:00
10/04/2023 22:15
Other stories
09/06/2023 23:31
09/06/2023 21:52
09/06/2023 13:54
09/06/2023 19:34
09/06/2023 18:45
09/06/2023 17:57
09/06/2023 14:21
09/06/2023 17:06
09/06/2023 16:27
09/06/2023 16:52
09/06/2023 17:48
09/06/2023 13:01
09/06/2023 15:15
09/06/2023 16:15
09/06/2023 21:50
09/06/2023 17:56
09/06/2023 14:43
09/06/2023 20:33
09/06/2023 07:00
08/06/2023 21:36
08/06/2023 10:56
08/06/2023 22:06
09/06/2023 18:25
09/06/2023 16:25
09/06/2023 13:03
09/06/2023 15:38
09/06/2023 21:26
09/06/2023 23:15
09/06/2023 18:00
09/06/2023 18:09
09/06/2023 10:37
09/06/2023 20:14
08/06/2023 20:47
09/06/2023 20:25
09/06/2023 12:54
09/06/2023 11:26
Eight warning signs to watch out for as cases of medieval disease surge in UK - Gloucestershire Live
09/06/2023 05:57
09/06/2023 12:56